Mark Simon

Sr. VP, Business Development, Amicus Therapeutics.

Companies

Cabaletta Bio, Inc.Board member Oct 24, 2019 to now¹
Amicus TherapeuticsSr. VP, Business Development May 30, 2007 to May 30, 2007²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Cabaletta Bio, Inc. CABA154,205 shares³$239.0K at $1.55Jan 21, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 21, 2026Bought 11,061 shares at $2.28 of Cabaletta Bio, Inc.³
Oct 18, 2022Bought 7,000 shares at $0.98 of Cabaletta Bio, Inc.⁴
Oct 18, 2022Bought 118,000 shares at $0.98 of Cabaletta Bio, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCabaletta Bio, Inc., Board member
2
SEC EDGARAmicus Therapeutics, Sr. VP, Business Development
3
SEC EDGARCabaletta Bio, Inc. shares after the filing of Jan 21, 2026
4
SEC EDGARForm 4 filed Oct 18, 2022